Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $793.02 | 37 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $352.61 | 12 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $88.42 | 5 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $69.94 | 4 | $0 (2024) |
| Lilly USA, LLC | $68.78 | 4 | $0 (2024) |
| Amgen Inc. | $59.51 | 3 | $0 (2024) |
| Medtronic, Inc. | $39.09 | 2 | $0 (2024) |
| Astellas Pharma US Inc | $33.68 | 2 | $0 (2024) |
| Exact Sciences Corporation | $30.35 | 2 | $0 (2023) |
| iRhythm Technologies, Inc. | $21.70 | 1 | $0 (2024) |
| AbbVie Inc. | $14.59 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $250.80 | 14 | Amgen Inc. ($59.51) |
| 2023 | $446.45 | 20 | Novo Nordisk Inc ($207.20) |
| 2022 | $95.77 | 3 | Novo Nordisk Inc ($95.77) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Inflammation | ||||||
| 06/05/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Biological | ||||||
| 05/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Inflammation | ||||||
| 04/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Obesity | ||||||
| 04/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Diabetes | ||||||
| 03/26/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Biological | ||||||
| 03/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Inflammation | ||||||
| 02/29/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: EndoVenous Therapies | ||||||
| 02/28/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Insomnia | ||||||
| 02/27/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: EndoVenous Therapies | ||||||
| 02/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Respiratory | ||||||
| 02/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Diabetes | ||||||
| 01/09/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Diabetes | ||||||
| 12/13/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: INSOMNIA | ||||||
| 11/07/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Oncology | ||||||
| 09/21/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Diabetes | ||||||
| 09/14/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Diabetes | ||||||
| 09/06/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/06/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: INSOMNIA | ||||||
| 06/22/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Oncology | ||||||
| 06/07/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Diabetes | ||||||
| 06/02/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: Obesity | ||||||
| 05/11/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: INSOMNIA | ||||||
| 04/20/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: INSOMNIA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 467 | 631 | $126,768 | $35,583 |
| 2022 | 6 | 140 | 150 | $25,691 | $8,641 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 123 | 189 | $55,755 | $15,486 | 27.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 139 | 208 | $40,768 | $11,969 | 29.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 34 | 34 | $11,832 | $4,152 | 35.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $8,136 | $1,472 | 18.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 73 | 93 | $2,976 | $781.20 | 26.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 16 | $1,872 | $594.02 | 31.7% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 12 | 13 | $3,172 | $527.15 | 16.6% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 17 | 17 | $731.00 | $294.27 | 40.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 14 | 14 | $714.00 | $242.34 | 33.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 21 | 29 | $812.00 | $63.80 | 7.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 63 | 68 | $13,328 | $4,529 | 34.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 20 | $5,900 | $1,981 | 33.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 13 | 13 | $4,524 | $1,623 | 35.9% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 13 | 13 | $559.00 | $230.23 | 41.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 12 | 12 | $612.00 | $208.68 | 34.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 22 | 24 | $768.00 | $70.56 | 9.2% |
About Jehon Amen
Jehon Amen is a Internal Medicine healthcare provider based in Mooresville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/26/2019. The National Provider Identifier (NPI) number assigned to this provider is 1336600121.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jehon Amen has received a total of $793.02 in payments from pharmaceutical and medical device companies, with $250.80 received in 2024. These payments were reported across 37 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($793.02).
As a Medicare-enrolled provider, Amen has provided services to 607 Medicare beneficiaries, totaling 781 services with total Medicare billing of $44,224. Data is available for 2 years (2022–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Mooresville, NC
- Active Since 03/26/2019
- Last Updated 08/15/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1336600121
Products in Payments
- Wegovy (Drug) $179.87
- Rybelsus (Drug) $102.93
- QUVIVIQ (Drug) $88.42
- Otezla (Drug) $59.51
- FARXIGA (Drug) $56.65
- VENASEAL (Device) $39.09
- MOUNJARO (Drug) $36.46
- Veozah (Drug) $33.68
- TRULICITY (Drug) $32.32
- Cologuard Collection Kit (Device) $30.35
- Saxenda (Drug) $22.79
- ZIO XT Patch (Device) $21.70
- Ozempic (Drug) $19.25
- SYNTHROID (Drug) $14.59
- JATENZO (Drug) $14.35
- AIRSUPRA (Drug) $13.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Mooresville
Dr. Kobina Wilmot, M.d, M.D
Internal Medicine — Payments: $48,697
Elmer Stout, Md, MD
Internal Medicine — Payments: $23,105
John Gatlin, M.d, M.D
Internal Medicine — Payments: $14,168
Luanne Gatlin, M.d, M.D
Internal Medicine — Payments: $7,171
Dr. Anthony Macasieb, D.o, D.O
Internal Medicine — Payments: $4,754
Christopher Zietlow, Md Phd, MD PHD
Internal Medicine — Payments: $2,012